Back to Search
Start Over
Molecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR : final report from AFTER-SKI
- Source :
- Leukemia
- Publication Year :
- 2021
- Publisher :
- Uppsala universitet, Hematologi, 2021.
-
Abstract
- n/a Funding Agencies|Lund University; Skane University Hospital
- Subjects :
- Oncology
Cancer Research
medicine.medical_specialty
Letter
Time Factors
Fusion Proteins, bcr-abl
MEDLINE
Phase II trials
03 medical and health sciences
0302 clinical medicine
Text mining
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Internal medicine
medicine
Humans
Hematologi
Protein Kinase Inhibitors
Chronic myeloid leukaemia
Clinical Trials as Topic
Cancer och onkologi
business.industry
Remission Induction
Hematology
Prognosis
Discontinuation
Europe
Withholding Treatment
030220 oncology & carcinogenesis
Cancer and Oncology
Neoplasm Recurrence, Local
business
030215 immunology
Subjects
Details
- Language :
- English
- ISSN :
- 24162418
- Database :
- OpenAIRE
- Journal :
- Leukemia
- Accession number :
- edsair.doi.dedup.....9c786095eec4bffe25dc0bbb82bce375